Zoledronate after denosumab discontinuation: Is repeated administrations more effective than single infusion?

CONCLUSIONS: In patients with uncontrolled CTX levels after Dmab withdrawal, two ZOL infusions at 6 months apart do not prevent BMD loss and FX.PMID:38609157 | DOI:10.1210/clinem/dgae224
Source: The Journal of Clinical Endocrinology and Metabolism - Category: Endocrinology Authors: Source Type: research